<DOC>
	<DOCNO>NCT02243059</DOCNO>
	<brief_summary>Advanced epithelial ovarian cancer high morbidity mortality . Patients present advanced stage ovarian cancer often cancer spread regional lymph node . Imaging strategy depict involve lymph node currently successful . The purpose study evaluate magnetic resonance imaging ( MRI ) gadofosveset trisodium contrast enhancement ( GDF-MRI ) diffusion weight imaging ( DW-MRI ) able identify involve lymph node preoperative setting . This could guide surgeon surgery dissect lymph node could lead optimal diagnosis/staging low possible morbidity . We want determine optimal image setting feasibility MRI detection pathological lymph node woman advance ( FIGO stage IIB-IV ) ovarian cancer undergo primary debulking surgery compare conventional imaging computer tomography ( CT ) .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Lymph Node Staging Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Nonpregnant female Expected FIGO stage IIBIV epithelial ovarian carcinoma Scheduled primary debulking surgery Written inform consent At least 18 year age . Patients estimate benefit neoadjuvant chemotherapy Ineligibility undergo MRI NonMR compatible metallic implant foreign body ( ferromagnetic aneurysm clip , pacemaker , neurostimulation system , etcetera ) . Claustrophobia Ineligibility receive gadofosveset contrast ( history contrast allergy , History prior allergic reaction active substance excipients Ablavarâ„¢ . Impaired kidney function ( Glomerular Filtration Rate &lt; 30 ml/min/1.73m2 ) . Previous paraaortic pelvic lymphadenectomy History malignant tumour . Pregnant lactating patient . Incapacitated subject</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Gadofosveset trisodium</keyword>
	<keyword>Nodal imaging</keyword>
</DOC>